期刊名称：HUMAN CELL
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Human Cell is the official English language journal of the Japan Human Cell Society, and publishes original research articles of studies using human cells, embryonic stem cells derived from animals or regenerative medicine using animal cells. Papers in any of the following categories will be considered:
- Research Articles
- Rapid Communications
- Reviews
- Letters to the Editor.
Indexed / Abstracted in
Current Abstracts (EBSCO)
Embase/Excerpta medica (Elsevier)
Embiology (Elsevier)
IBIDS: International Bibliographic Information on Dietary Supplements
Index Medicus/MEDLINE (NLM)
InfoTrac
INIS: International Nuclear Information System Database (IAEA)
Journal Citation Reports/Science Edition (Thomson ISI)
MEDLINE/PubMed (NLM)
Science Citation Index Expanded (also known as SciSearch®)
SCOPUS (Elsevier)
Instructions to Authors
AIMS AND SCOPE
Human Cell is the official English language journal of the Japan Human Cell Society, and publishes original research articles of studies using
human cells, embryonic stem cells derived from animals or regenerative medicine using animal cells. Papers in any of the following categories will
be considered: Research Articles, Rapid Communications, Reviews, and Letters to the Editor.
EDITORIAL REVIEW AND ACCEPTANCE
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are double-blind peer reviewed by two anonymous reviewers and the Editor. Final acceptance or rejection rests with the Editorial Board, who reserves the right to refuse any material for publication.
Manuscripts should be written so that they are intelligible to the professional reader who is not a specialist in the particular field. They should be written in a clear, concise, direct style. Where contributions are judged as acceptable for publication on the basis of scientific content, the Editor and the Publisher reserve the right to modify typescripts to eliminate ambiguity and repetition and improve communication between author and reader. If extensive alterations are required, the manuscript will be returned to the author for revision.
A paper can be rejected without undergoing the peer-review process if the Editor determines that the content is inappropriate for the journal. Authors usually receive the editorial decision within 6 weeks of the manuscript's arrival at the Editorial Office.
SUBMISSION OF MANUSCRIPTS
Manuscripts should be submitted online at http://mc.manuscriptcentral.com/huc. If there are any problems using the site or managing a manuscript, please contact ScholarOne Manuscripts technical support, Scholar One Inc. (email: Support@ScholarOne.com). For authors unable to submit their manuscript online, please consult with the Editorial Office (email: ishiwata-hcb@sepia.ocn.ne.jp). Authors must supply an email address as all correspondence will be by email. Two files should be supplied: the covering letter and the manuscript (in Word or rich text format (.rtf)). The covering letter should be uploaded as a file not for review in keeping with the double-blind review process.
All articles submitted to the Journal must comply with these instructions. Failure to do so will result in return of the manuscript and possible delay in publication.
• Submissions should be double-spaced.
• All margins should be at least 30 mm.
• All pages should be numbered consecutively in the top right-hand corner, beginning with the title page.
• Do not use Enter at the end of lines within a paragraph.
• Turn the hyphenation option off; include only those hyphens that are essential to the meaning.
• Specify any special characters used to represent non-keyboard characters.
• Take care not to use l (ell) for 1 (one), O (capital o) for 0 (zero) or ß (German esszett) for β (Greek beta).
• Use a tab, not spaces, to separate data points in tables. If you use a table editor function, ensure that each data point is contained within a unique cell (i.e. do not use carriage returns within cells).
Each figure should be supplied as a separate file, with the figure number incorporated in the file name. For submission, low-resolution figures saved as .jpg or .bmp files should be uploaded, for ease of transmission during the review process. Upon acceptance of the article, high-resolution figures (at least 300 d.p.i.) saved as .eps or .tif files should be uploaded. Digital images supplied only as low-resolution files cannot be used.
Further instructions are available at the submission site.
Please note that Word 2007 is not yet compatible with journal production systems. Unfortunately, the journal cannot accept Microsoft Word 2007 documents until such time as a stable production version is released. Please use Word's 'Save As' option therefore to save your document as an older (.doc) file type.
Covering letter
Papers are accepted for publication in the Journal on the understanding that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium. This must be stated in the covering letter.
The covering letter must also contain an acknowledgment that all authors have contributed significantly, and that all authors are in agreement with the content of the manuscript. In keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author's contribution to the paper is to be quantified.
Authors must declare any financial support or relationships that may pose conflict of interest by disclosing at the time of submission any financial arrangements they have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product. Such information will be held in confidence while the paper is under review and will not influence the editorial decision but, if the article is accepted for publication, the Editor will usually discuss with the authors the manner in which such information is to be communicated to the reader.
If tables or figures have been reproduced from another source, a letter from the copyright holder (usually the Publisher), stating authorization to reproduce the material, must be attached to the covering letter.
Author material archive policy
Authors who require the return of any submitted material that is accepted for publication should inform the Editorial Office after acceptance. If no indication is given that author material should be returned, Blackwell Publishing will dispose of all hardcopy and electronic material two months after publication.
ETHICAL CONSIDERATIONS
Authors must state that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and that it conforms to the provisions of the Declaration of Helsinki (as revised in Tokyo 2004), available at http://www.wma.net/e/policy/b3.htm. Human Cell retains the right to reject any manuscript on the basis of unethical conduct of either human or animal studies.
All investigations on human subjects must include a statement that the subject gave informed consent. Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized (or an eye bar should be used).
In general, submission of a case report should be accompanied by the written consent of the subject (or parent/guardian) before publication; this is particularly important where photographs are to be used or in cases where the unique nature of the incident reported makes it possible for the patient to be identified. While the Editorial Board recognizes that it might not always be possible or appropriate to seek such consent, the onus will be on the authors to demonstrate that this exception applies in their case.
When the research is carried out in areas for which research permits are required (e.g. nature reserves), or when it deals with organisms for which collection or import/export permits are required (e.g. protected species), the authors must clearly detail obtaining these permits in the Acknowledgments section.
COPYRIGHT
Authors publishing in the Journal will be asked to sign an Exclusive Licence Form. In signing the form it is assumed that authors have obtained permission to use any copyrighted or previously published material. All authors must read and agree to the conditions outlined in the form, and must sign the form or agree that the corresponding author can sign on their behalf. Articles cannot be published until a signed form has been received. Authors can download the form from http://www.blackwellpublishing.com/pdf/huc_elf-05.pdf.
STYLE OF THE MANUSCRIPT
Manuscripts should follow the style of the Vancouver agreement detailed in the International Committee of Medical Journal Editors' revised 'Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication', as presented at http://www.ICMJE.org/.
Spelling. The Journal uses US spelling and authors should therefore follow the latest edition of the Merriam-Webster's Collegiate Dictionary.
Units. All measurements must be given in SI or SI-derived units. Please go to the Bureau International des Poids et Mesures (BIPM) website at http://www.bipm.fr for more information about SI units.
Abbreviations. Abbreviations should be used sparingly - only where they ease the reader's task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
Trade names. Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses. Unfamiliar compounds other than drugs must also be defined, when first used, by their correct systematic names. Systematic chemical names should conform to the usage given in the indexes of Chemical Abstracts.
Scientific names. Upon its first use in the title, abstract and text, the common name of a species should be followed by the scientific name (genus, species and authority) in parentheses. However, for well-known species, the scientific name may be omitted from the article title. If no common name exists in English, the scientific name should be used only.
Genetic nomenclature. Standard genetic nomenclature should be used. For further information, including relevant websites, authors should refer to the genetic nomenclature guide in Trends in Genetics (Elsevier Science, 1998).
Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL and GenBank on a daily basis. The suggested wording for referring to accession-number information is: 'These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345.'
Addresses are as follows:
DNA Data Bank of Japan (DDBJ) http://www.ddbj.nig.ac.jp
EMBL Nucleotide Sequence Submissions http://www.ebi.ac.uk
GenBank http://www.ncbi.nlm.nih.gov
PARTS OF THE MANUSCRIPT
The length of an article (excluding references, figure legends, tables and appendices) should not exceed 3600 words. Letters to the Editor should not exceed 1000 words, and no more than 10 references may be cited.
Manuscripts should be presented in the following order: (i) title page, (ii) abstract and key words, (iii) text, (iv) acknowledgments, (v) references, (vi) appendices, (vii) figure legends, (viii) tables (each table complete with title and footnotes) and (ix) figures. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
Title page
As articles are double-blind reviewed, material that might identify authorship of the paper should be placed on a cover sheet; this will be detached before the paper is sent to a referee.
The title page should contain (i) the title of the paper, (ii) the full names of the authors and (iii) the addresses of the institutions at which the work was carried out together with (iv) the full postal and email address, plus facsimile and telephone numbers, of the author to whom correspondence about the manuscript should be sent. The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.
The title should be short, informative and contain the major key words. Do not use abbreviations in the title. A short running title (less than 40 characters, including spaces) should also be provided.
Abstract and key words
All articles except Letters to the Editor must have a brief abstract that states in 250 words or fewer the purpose, basic procedures, main findings and principal conclusions of the study. The abstract should not contain abbreviations or references.
Five key words, for the purposes of indexing, should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at http://www.nlm.nih.gov/mesh/meshhome.html.
Text
Authors should use the following subheadings to divide the sections of their manuscript: Introduction, Methods, Results and Discussion.
Acknowledgments
The source of financial grants and other funding must be acknowledged, including a frank declaration of the authors' industrial links and affiliations. The contribution of colleagues or institutions should also be acknowledged. Personal thanks and thanks to anonymous reviewers are not appropriate.
References
We recommend the use of a tool such as EndNote or Reference Manager for reference management and formatting.
EndNote reference styles can be searched for here:
http://www.endnote.com/support/enstyles.asp
The Vancouver system of referencing should be used (examples are given below). In the text, references should be cited using superscript Arabic numerals in the order in which they appear. If cited in tables or figure legends, number according to the first identification of the table or figure in the text.
In the reference list, cite the names of all authors when there are six or fewer; when seven or more, list the first three followed by et al. Do not use ibid. or op cit. Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. Smith A, 2000, unpublished data). All citations mentioned in the text, tables or figures must be listed in the reference list.
Names of journals should be abbreviated in the style used in Index Medicus.
Authors are responsible for the accuracy of the references.
Vancouver journals:
Journal article
1 Vega KJ, Pina I, Krevsky B. Heart transplantation is associated with an increased risk for pancreatobiliary disease. Ann Intern Med 1996; 124: 980-983.
Journal articles published ahead of issue (print or online)
2 Danjoh I, Sone H, Noda N et al. Is parainfluenza virus a threatening virus for human cancer cell lines? Hum Cell 2009. doi: 10.1111/j.1749-0774.2009.00071.x
Book
3 Ringsven MK, Bond D. Gerontology and Leadership Skills for Nurses, 2nd edn. Albany, NY: Delmar Publishers, 1996.
Chapter in a Book
4 Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management, 2nd edn. New York: Raven Press, 1995; 465-78.
Journal article on the Internet
5 Abbod S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [serial on the Internet] 2002 [cited 12 Aug 2002]; 102. Available from: http://www.nursingworld.org/AJN/2002/june/wawatch.htm
Homepage/website
Cancer-Pain.org [homepage on the Internet]. New York: Association of Cancer Online Resources [updated 16 May 2002; cited 9 Jul 2002]. Available from: http://www.cancer_pain.org/
Part of a homepage/website
American Medical Association [homepage on the Internet]. Chicago: American Medical Association [updated 23 Aug 2001; cited 12 Aug 2002]. AMA Office of group Practice Liaison. Available from: http://www.ama_assn.org/ama/pub/category/1736.htm
We recommend the use of a tool such as EndNote or Reference Manager for reference management and formatting.
EndNote reference styles can be searched for here:
http://www.endnote.com/support/enstyles.asp
Reference Manager reference styles can be searched for here:
http://www.refman.com/support/rmstyles.asp
Tables
Tables should be self-contained and complement, but not duplicate, information contained in the text. Number tables consecutively in the text in Arabic numerals. Type tables on a separate page with the legend above. Legends should be concise but comprehensive - the table, legend and footnotes must be understandable without reference to the text. Vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.
Figures
All illustrations (line drawings and photographs) are classified as figures. Figures should be cited in consecutive order in the text. Figures should be sized to fit within the column (80.5 mm), intermediate (110 mm) or the full text width (168 mm). Magnifications should be indicated using a scale bar on the illustration.
Line figures should be sharp, black and white graphs or diagrams, drawn professionally or with a computer graphics package. Lettering must be included and should be sized to be no larger than the journal text.
Figure legends
Type figure legends on a separate page. Legends should be concise but comprehensive - the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.
Previously published material
If a figure or table has already been published, acknowledge the original source in the legend and submit written permission from the copyright holder to reproduce the material. Permission is required irrespective of authorship or publisher, except for documents designated as "public domain".
BLACKWELL AUTHOR SERVICES
Author Services enables authors to track their article, once it has been accepted, through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated emails at key stages of production so they do not need to contact the production editor to check on progress. Visit http://authorservices.wiley.com/bauthor/ for more details on online production tracking and for a wealth of resources, including FAQs and tips on article preparation, submission and more.
PROOFS
It is essential that corresponding authors supply an email address to which correspondence can be emailed while their article is in production.
Word files of edited articles will be sent for checking via email, and should be returned to the Publisher. It is essential that these files are checked carefully, as the cost of changes made at a later stage may be charged to the author. Full instructions on how to correct and return the file will be attached to the email.
Notification of the URL from where to download a Portable Document Format (PDF) typeset page proof, associated forms and further instructions will be sent by email to the corresponding author. The purpose of the PDF proof is a final check of the layout, and of tables and figures. Alterations other than the essential correction of errors are unacceptable at PDF proof stage. The proof should be checked, and approval to publish the article should be emailed to the Publisher by the date indicated, otherwise, it may be signed off on by the Editor or held over to the next issue.
OFFPRINTS
A free PDF offprint will be supplied to the corresponding author. A minimum of 50 additional offprints will be provided upon request, at the author's expense. These paper offprints may be ordered online. Please visit http://offprint.cosprinters.com/, fill in the necessary details and ensure that you type information in all of the required fields.
If you have queries about offprints please email offprint@cosprinters.com
PUBLICATION FEES
A publication fee of ¥30,000/US$270 per page is required if a manuscript is in excess of four printed pages. Authors outside of Japan will be invoiced by Blackwell Publishing. Authors in Japan will be invoiced by the Society.
COLOR FIGURE CHARGE
Up to two color figures will be published free of charge if judged relevant and of good quality. The cost of color reproduction for the third and any subsequent color figures will be chargeable to the author at a cost of A$550/US$265/¥32,000 per figure.
BLACKWELL JOURNALS ONLINE
Visit the Human Cell home page at http://www.blackwellpublishing.com/huc for more information, and Blackwell Publishing's web pages for submission guidelines and digital graphics standards at http://authorservices.wiley.com/bauthor/journal.asp and http://authorservices.wiley.com/bauthor/illustration.asp. This journal is available online at Wiley InterScience. Visit www3.interscience.wiley.com to search the articles and register for table of contents and e-mail alerts.
EARLY VIEW
Human Cell is covered by Wiley-Blackwell's Early View service. Early View articles are complete full-text articles published online in advance of their
publication in a printed issue. Early View articles are complete and final, therefore no changes can be made after online publication. Early View articles
are given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article.
EDITORIAL OFFICE ADDRESS
Isamu Ishiwata (Editor-in-Chief)
Human Cell Editorial Office
c/o Institute Cell Biology, Ishiwata Hospital,
1-4-21 Kamimito, Mito-shi,
Ibaraki-ken 310-0041, Japan
Tel: +81-29-221-2553; fax: +81-29-221-1012
Email: ishiwata-hcb@sepia.ocn.ne.jp
Editorial Board
Editor-in-Chief
Isamu Ishiwata
Deputy Editors
Damon C. Herbert
Hiroaki Kataoka
Editorial Board
Kiyoshi Ando
Toshiyoshi Fujiwara
Keiichi Fukuda
Takashi Hirano
Hiroshi Ishikawa
Keiji Kawamoto
Yoshihiro Kikuchi
Kunihiko Kurosaki
Takahide Mori
Masato Nishida
Masatsugu Ohta
Kahei Sato
Nao Suzuki
Yutaka Shimada
Masaaki Tachibana
Sonshin Takao
Kumiko Tsuboi
Masatsugu Ueda
Advisory Board
L. S. Cram
Zbigniew Darzynkiewicz
Asao Hirano
Jun Minowada
Arvid B. Maunsbach
|
